VANCOUVER, British Columbia, Sept. 25, 2025 (GLOBE NEWSWIRE) -- AlphaGen Intelligence Corp. (CSE:AIC, OTC:APETF, FSE: G4G)) ("AlphaGen" or the "Company") announces a non-brokered private placement financing (the "Offering") consisting of a minimum of 2,222,222 units of the Company (each, a "Unit") and a maximum of 3,900,000 units of the Company, at a price of C$0.135 per Unit, for gross minimum proceeds of up to $300,0000 and a gross maximum proceeds of C$526,500. Each Unit shall be comprised of one common share in the capital of the Company (each, a "Share") and one Share purchase warrant ("Warrant"), with each Warrant entitling the holder to purchase one Share at a price of C$0.18 for a period of 24 months from Closing (as defined herein). The Warrants are subject to a 60-day hold period.
The Offering is anticipated to close on or about November 8, 2025 ("Closing"), subject to the satisfaction of certain conditions, including, but not limited to, the receipt of all necessary regulatory and other approvals. The net proceeds of the Offering are intended to be used for general administrative expenditures and general working capital purposes.
The Company intends to complete the Offering pursuant to the "listed issuer financing exemption" under Part 5A of National Instrument 45-106, Prospectus Exemptions ("NI 45-106") and the Coordinated Blanket Order 45-935 Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the "Life Exemption"). Subject to compliance with applicable regulatory requirements and in accordance with NI 45-106, the securities issuable under the Offering will be offered for sale to purchasers resident in all of the provinces of Canada (except Quebec) pursuant to the listed issuer financing exemption under Part 5A.2 of NI 45-106. Pursuant to the LIFE Exemption, the securities issued to subscribers will not be subject to resale restrictions in accordance ...
